Researchers at Utrecht University and Erasmus Medical Center in the Netherlands, in alliance with China-based firm Harbour BioMed, have identified a fully human monoclonal antibody with activity against the novel coronavirus, SARS-CoV-2.
According to the team, the antibody could prevent SARS-CoV-2 virus from infecting cultured cells. The Nature Communications journal published the findings.
The discovery could facilitate a fully human antibody for the treatment and prevention of Covid-19, the respiratory disease caused by SARS-CoV-2.
Utrecht University research leader Berend-Jan Bosch said: “This research builds on the work our groups have done in the past on antibodies targeting the SARS-CoV that emerged in 2002/2003. “Using this